Oct4 Recombinant Rabbit Monoclonal Antibody [SD0750]
Catalog# ET1612-20
Oct4 Recombinant Rabbit Monoclonal Antibody [SD0750]
-
WB
-
IF-Cell
-
IF-Tissue
-
IHC-P
-
IP
-
FC
-
ChIP
-
Human
-
Mouse
-
unconjugated
Overview
Product Name
Oct4 Recombinant Rabbit Monoclonal Antibody [SD0750]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within human Oct4 aa 20-60.
Species Reactivity
Human, Mouse
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, IP, FC, ChIP
Molecular Weight
Predicted band size: 39 kDa
Positive Control
F9 cell lysate, NCCIT cell lysate, NCCIT, F9, mouse liver tissue, human seminoma tissue tissue.
Conjugation
unconjugated
Clone Number
SD0750
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000-1:8,000
-
IF-Cell
-
1:1,000-1:2,000
-
IF-Tissue
-
1:1,000-1:2,000
-
IHC-P
-
1:500-1:4,000
-
IP
-
Use at an assay dependent concentration.
-
FC
-
1ug/mL
-
ChIP
-
Use 0.5~2 μg for 25 μg of chromatin.
Target
Function
POU5F1 (POU domain, class 5, transcription factor 1), also known as octamer-binding transcription factor-3 (Oct-3, OTF3), octamer-binding transcription factor-4 (Oct-4, Otf-4) and Oct-3/4, modulates embryonic stem (ES) cell populations by influencing lineage commitment. Oct-3/4 sustains stem-cell self-renewal and differentiation pathways. Transcription factors containing the POU homeodomain regulate tissue-specific gene expression in lymphoid and pituitary differentiation and in early mammalian development. Oct-3/4 is capable of inducing rapid proliferation and tumorigenic properties of ES cells through activation of the UTF1 gene. In humans, two Oct-3/4 isoforms contribute to influencing the undifferentiated phenotype of ES cells. Oct-3/4 pseudogenes localizing to human chromosomes 10 and 8 are reported to be transcribed in certain cancer cell lines and tissues.
Background References
1. Vessoni AT et al. Cockayne syndrome-derived neurons display reduced synapse density and altered neural network synchrony. Hum Mol Genet 25:1271-80 (2016).
2. Fang L et al. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma. Int J Mol Med 38:172-82 (2016).
Sequence Similarity
Belongs to the POU transcription factor family. Class-5 subfamily.
Tissue Specificity
Expressed in developing brain. Highest levels found in specific cell layers of the cortex, the olfactory bulb, the hippocampus and the cerebellum. Low levels of expression in adult tissues.
Post-translational Modification
Sumoylation enhances the protein stability, DNA binding and transactivation activity. Sumoylation is required for enhanced YES1 expression.; Ubiquitinated; undergoes 'Lys-63'-linked polyubiquitination by WWP2 leading to proteasomal degradation.; ERK1/2-mediated phosphorylation at Ser-111 promotes nuclear exclusion and proteasomal degradation. Phosphorylation at Thr-235 and Ser-236 decrease DNA-binding and alters ability to activate transcription.
Subcellular Location
Cytoplasm, Nucleus.
Synonyms
Octamer binding transcription factor 4 antibody
MGC22487 antibody
Oct 3 antibody
Oct 4 antibody
Oct-3 antibody
Oct-4 antibody
OCT3 antibody
Oct4 antibody
Octamer binding protein 3 antibody
Octamer binding protein 4 antibody
ExpandOctamer binding transcription factor 4 antibody
MGC22487 antibody
Oct 3 antibody
Oct 4 antibody
Oct-3 antibody
Oct-4 antibody
OCT3 antibody
Oct4 antibody
Octamer binding protein 3 antibody
Octamer binding protein 4 antibody
Octamer binding transcription factor 3 antibody
Octamer-binding protein 3 antibody
Octamer-binding protein 4 antibody
Octamer-binding transcription factor 3 antibody
OTF 3 antibody
OTF 4 antibody
OTF-3 antibody
OTF3 antibody
OTF4 antibody
PO5F1_HUMAN antibody
POU class 5 homeobox 1 antibody
POU domain class 5 transcription factor 1 antibody
POU domain transcription factor OCT4 antibody
POU domain, class 5, transcription factor 1 antibody
POU-type homeodomain-containing DNA-binding protein antibody
POU5F1 antibody
CollapseImages
-
Immunocytochemistry analysis of NCCIT cells labeling Oct4 with Rabbit anti-Oct4 antibody (ET1612-20) at 1/2,000 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Oct4 antibody (ET1612-20) at 1/2,000 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of F9 cells labeling Oct4 with Rabbit anti-Oct4 antibody (ET1612-20) at 1/2,000 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Oct4 antibody (ET1612-20) at 1/2,000 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
☑ Knockout (KO)
Western blot analysis of Oct4 with anti-Oct4 antibody (ET1612-20) at 1/2,000 dilution.
Lane 1: Wild-type NCCIT whole cell lysate.
Lane 2: Oct4 knockout NCCIT whole cell lysate.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary Anti-Oct4 antibody (ET1612-20, 1/2,000) and Anti-HSP90 antibody (ET1605-56, 1/10,000) were used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG H&L (HRP) Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of Oct4 on different lysates with Rabbit anti-Oct4 antibody (ET1612-20) at 1/2,000 dilution.
Lane 1: F9 cell lysate
Lane 2: NCCIT cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 39 kDa
Observed band size: 45 kDa
Exposure time: 1 minute 59 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1612-20) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Application: IF-Tissue
Species: Human
Site: seminoma
Sample: Paraffin-embedded section
Antibody concentration: 1/1,000 -
Immunohistochemical analysis of paraffin-embedded human seminoma tissue with Rabbit anti-Oct4 antibody (ET1612-20) at 1/4,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1612-20) at 1/4,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Oct4 was immunoprecipitated in 0.2mg NCCIT cell lysate with ET1612-20 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using ET1612-20 at 1/2,000 dilution. Anti-Rabbit IgG for IP Nano-secondary antibody (NBI01H) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: NCCIT cell lysate (input)
Lane 2: ET1612-20 IP in NCCIT cell lysate
Lane 3: Rabbit IgG instead of ET1612-20 in NCCIT cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 1 minute 40 seconds -
Flow cytometric analysis of NCCIT cells labeling Oct4.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1612-20, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Chromatin immunoprecipitations were performed with cross-linked chromatin from NCCIT cells with Oct4 (ET1612-20) or Normal Rabbit IgG according to the ChIP protocol. The enriched DNA was quantified by real-time PCR using indicated primers. The amount of immunoprecipitated DNA in each sample is represented as signal relative to the total amount of input chromatin, which is equivalent to one.
-
Immunohistochemical analysis of paraffin-embedded human seminoma tissue with Rabbit anti-Oct4 antibody (ET1612-20) at 1/1,000 dilution.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins. The section was incubated with ET1612-20 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Generation of human induced pluripotent stem cell line derived from dilated cardiomyopathy with compound heterozygous TTN and TAB2 variants
Journal: Stem Cell Research
DOI: 10.1016/j.scr.2026.103916
IF: 0.7
Application: IF-cell
Reactivity: Human
Publish date: 2026 Jan
-
Chemical reprogramming of human blood cells to pluripotent stem cells
Journal: Cell Stem Cell
DOI: 10.1016/j.stem.2025.07.003
IF: 20.4
Application: IF-cell
Reactivity: Human
Publish date: 2025 Jul
-
Polycationic Photosensitizers as Effective Anticancer Agents That Destroy Cancer Stem Cells, Cancer Vascularization and Induce Protective Desmoplastic Reaction around Lung Cancers
Journal: Preprint And Has Not Been Certified By Peer Review
DOI:
IF:
Application: IHC-P
Reactivity: Human
Publish date: 2024 May
-
Clinical Characteristics and Induced Pluripotent Stem Cells (iPSCs) Disease Model of Harel-Yoon Syndrome Caused by Compound Heterozygous ATAD3A Variants
Journal: Research Square
DOI:
IF:
Application: IF-cell
Reactivity: Human
Publish date: 2024 Dec
-
Diminished GALNS activity in induced pluripotent stem cells of mucopolysaccharidosis IVA caused by compound p. S162Y and p. C165F mutation
Journal: Quarterly Journal Of Management
DOI:
IF: 7.3
Application: IF-cell
Reactivity: Human
Publish date: 2024 Aug
-
Photodynamic therapy of lung cancer with photosensitizers based on polycationic derivatives of synthetic bacteriochlorin (experimental study)
Journal: Photodiagnosis And Photodynamic Therapy
DOI:
IF: 3.3
Application: IHC-P
Reactivity: Human,Mouse
Publish date: 2023 Jun
-
Hyaluronic acid mediated Fe3O4 nanocubes reversing the EMT through targeted cancer stem cell
Journal: Colloids And Surfaces B: Biointerfaces
DOI:
IF:
Application: WB
Reactivity: Human
Publish date: 2023 Feb
-
N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc
Journal: Cancer Letters
DOI:
IF: 6.375
Application: Co-IP,WB
Reactivity: Human
Publish date: 2017 Aug
-
Aire Promotes the Self-Renewal of Embryonic Stem Cells Through Lin28
Journal: Stem Cells And Development
DOI:
IF: 3.562
Application: WB
Reactivity: Mouse
Publish date: 2012 Oct